erode margins and revenue growth. Boston Scientific (NYSE: BSX) Lack of product development has meant missed market opportunity. Wendy's/Arby's (NYSE: WEN) Fierce pricing competition will make it difficult to rebound from recent losses. Any pricing...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Big-Time Contrarianism for Small-Time Contrarians
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account